News
WHIPPANY, NJ, USA I April 29, 2025 I Bayer announced today initiation of a Phase I clinical trial with 225Ac-GPC3 (BAY 3547926), an investigational targeted ...
Most editorial rooms have covered the excesses of Trump’s first hundred days well and have adequately responded to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback